InMed Pharmaceuticals Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q3 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
InMed Pharmaceuticals Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q3 2021 to Q3 2024.
  • InMed Pharmaceuticals Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -2.71 USD/shares, a 82.2% increase year-over-year.
  • InMed Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2024 was -1.01 USD/shares, a 68.9% increase from 2023.
  • InMed Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2023 was -3.25 USD/shares, a 90.2% increase from 2022.
  • InMed Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2022 was -33.2 USD/shares, a 12.6% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$3 +$12.50 +82.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q4 2023 -$14 $0 +$0.72 +79.1% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q3 2023 -$14 -$15 -$11 -275% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$3 $2.32 +$15.50 Apr 1, 2023 Jun 30, 2023 10-K 2024-09-30
Q1 2023 -$19 -$1 +$5.54 +90.2% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$24 -$1 +$6.82 +88.2% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 -$31 -$4 +$2.11 +34.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$33 -$13 Apr 1, 2022 Jun 30, 2022 10-K 2023-09-29
Q1 2022 -$6 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$8 Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-17
Q3 2021 -$6 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.